Business Wire
-

November 5, 2026
New RZ/T2N MPU Integrates Motor Control, Industrial Ethernet and Application Processing for Robots and Industrial Equipment
Nov. 5, 2026 13:00 UTC New RZ/T2N MPU Integrates Motor Control, Industrial Ethernet and Application Processing for Robots and Industrial Equipment Handles motor control for up to four axes, industrial Ethernet and Linux application processing on a single chip Serves as both network controller and device supporting PLCs to multi-axis servos and industrial robots Reduces board area and system complexity compared with conventional multi-chip configurations, enabling smaller equipment and faster development Will be demonstrated live at electronica 2026, November 10–13 in Munich, Germany (Renesas booth: Hall C5, Stand 479). TOKYO–(BUSINESS WIRE)– Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today introduced the RZ/T2N, a 64-bit microprocessor (MPU) […]
-
November 5, 2026
Nidec Announces Renewal of Commitment Line Agreement
Nov. 5, 2026 06:40 UTC Nidec Announces Renewal of Commitment Line Agreement KYOTO, Japan–(BUSINESS WIRE)– Nidec Corporation (TOKYO:6594; OTC US: NJDCY) (the “Company”) hereby announces that the Company made a resolution today, November 5, 2026, to renew its commitment line agreements with its main creditor banks, MUFG Bank, Ltd. and Sumitomo Mitsui Banking Corporation, for a total of 600 billion yen, and has executed the agreements on the same date as follows. 1. Purpose for renewal of Commitment Line Agreement Upon the maturity of the term on the agreements, to keep securing flexible and stable funding capacity and maintain its financial health. 2. Overview of Commitment Line Agreement (After Renewal) […]
-

November 5, 2026
SkyDrive Signs MOU with Goyang Special City and Verty to Accelerate Commercial eVTOL Deployment in South Korea
Nov. 5, 2026 04:15 UTC SkyDrive Signs MOU with Goyang Special City and Verty to Accelerate Commercial eVTOL Deployment in South Korea Tripartite partnership targets 2028 commercial flight operations and regional ecosystem development across the Seoul Capital Area TOYOTA, Japan–(BUSINESS WIRE)– SkyDrive Inc. (“SkyDrive”), a leading compact eVTOL aircraft (*1) developer based in Japan, announced that it has signed a tripartite memorandum of understanding (MOU) with Goyang Special City, a prominent South Korean metropolis leading vertiport development as the Seoul Capital Area hub for South Korea’s national urban air mobility (K-UAM) initiative, and Verty Co. Ltd. (“Verty”), a Seoul-based company establishing integrated systems across flight operations, air traffic management and […]
-

November 5, 2026
World-First Achievement: SUSMED’s Blockchain-Based Clinical Trial System Supports Successful Marketing Authorization for Pharmaceutical Product
Nov. 5, 2026 04:00 UTC World-First Achievement: SUSMED’s Blockchain-Based Clinical Trial System Supports Successful Marketing Authorization for Pharmaceutical Product – Pioneering Solutions for Drug Lag and Loss – TOKYO–(BUSINESS WIRE)– SUSMED, Inc. (TOKYO:4263) announced that “SUSMED SourceDataSync®” (“SUSMED SDS”), its proprietary blockchain-based clinical trial system, has contributed to obtaining marketing authorization for a pharmaceutical product1,2,3. This marks the world’s first pharmaceutical approval based on the results of an industry-sponsored clinical trial utilizing blockchain technology4. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261029041063/en/ SUSMED SDS enables the conduct of high quality and efficient clinical trials. 1: https://newsroom.viatris.com/2026-09-16-Viatris-Announces-Approval-of-WAKIX-R-Pitolisant-in-Japan,-a-First-in-Class-Treatment-for-Narcolepsy-and-Excessive-Daytime-Sleepiness-Associated-With-Obstructive-Sleep-Apnea-Syndrome 2 :”Aculys Pharma Commences Phase 3 Clinical Trial of Pitolisant in […]
-
November 5, 2026
FiRa Consortium Establishes Japan Committee to Advance FiRa Technology in Japan
Nov. 4, 2026 23:00 UTC FiRa Consortium Establishes Japan Committee to Advance FiRa Technology in Japan New regional committee will engage Japanese stakeholders, support local adoption, and bring market perspectives to FiRa use case and specification development BEAVERTON, Ore.–(BUSINESS WIRE)– The FiRa® Consortium has established the FiRa Japan Committee, a permanent regional committee dedicated to engaging stakeholders in Japan and supporting the adoption of FiRa technology. The committee will also bring Japanese requirements and perspectives to FiRa use case and specification development. The committee will give FiRa members and other key stakeholders a forum to exchange information, identify adoption challenges, and share feedback with FiRa Working Groups. It will also […]
-
November 5, 2026
ERI’s John Shegerian Shares What All Businesses Can Learn From Japanese Culture in Newsweek Opinion Piece
Nov. 4, 2026 19:34 UTC ERI’s John Shegerian Shares What All Businesses Can Learn From Japanese Culture in Newsweek Opinion Piece NEW YORK–(BUSINESS WIRE)–John Shegerian, the Chairman and CEO of ERI, the leading international material resource recovery, ITAD and tech reuse and recycling company, has written an opinion editorial piece, published in Newsweek, describing how businesses globally can learn from the worldview of Japanese culture. Shegerian’s article highlights the Japanese cultural focus on cleanliness, respect and the business philosophy called Sampo-yoshi (where deals should be good for the seller, good for the buyer, and good for society); and explores how these cultural tenets, evident in Japanese lifestyles, business and even […]
-
November 5, 2026
Taiho Oncology and Taiho Pharmaceutical to Present Data from AZTOUND Trial Evaluating Oral Azacitidine and Cedazuridine in Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia at the 68th American Society of Hematology Annual Meeting
Nov. 4, 2026 16:01 UTC Taiho Oncology and Taiho Pharmaceutical to Present Data from AZTOUND Trial Evaluating Oral Azacitidine and Cedazuridine in Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia at the 68th American Society of Hematology Annual Meeting PRINCETON, N.J. & TOKYO–(BUSINESS WIRE)– Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., today announced that data from the AZTOUND trial evaluating oral azacitidine and cedazuridine (ASTX030) in patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML) will be shared in an oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition, to be held from December 12–15 in New Orleans. This press release features multimedia. View the […]
-

November 4, 2026
Beyond Kobe Beef and Sake: HOCHO KNIFE (Import Japan.com) Opens Its First Japanese Knife Store in Kobe
Nov. 4, 2026 14:00 UTC Beyond Kobe Beef and Sake: HOCHO KNIFE (Import Japan.com) Opens Its First Japanese Knife Store in Kobe Explore around 700 knives and accessories; meet three Echizen bladesmiths KOBE, Japan–(BUSINESS WIRE)– HOCHO KNIFE, a Japanese kitchen knife specialist that has delivered more than 200,000 authentic Japanese knives to customers in over 80 countries, will open its first physical store in Kobe’s Sannomiya shopping district on November 14, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261028274743/en/ Store front of HOCHO KNIFE At the grand opening, three bladesmiths from Echizen will meet visitors who will be able to experience the craftsmanship and beauty of […]
-
November 4, 2026
Ono Pharma Receives Orphan Medicinal Product Designation for Sapablursen from European Commission and Plans to Present Trial-in-Progress Poster at ASH 2026
Nov. 4, 2026 14:00 UTC Ono Pharma Receives Orphan Medicinal Product Designation for Sapablursen from European Commission and Plans to Present Trial-in-Progress Poster at ASH 2026 Design of Phase 3 INTREPID study of sapablursen in polycythemia vera to be presented at the 68th American Society of Hematology Annual Meeting Sapablursen has also received Orphan Drug Designations for polycythemia vera in the United States, Japan and Europe OSAKA, Japan–(BUSINESS WIRE)– Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) today announced that the European Commission has granted Orphan Medicinal Product Designation to sapablursen (ONO-0530) in polycythemia vera (PV). Sapablursen has previously received Fast Track Designation in January […]
-

November 4, 2026
Asahi Kasei Signs MOU With Power to Hydrogen to Accelerate Commercialization of AEM Water Electrolysis for Clean Hydrogen Production
Nov. 4, 2026 13:30 UTC Asahi Kasei Signs MOU With Power to Hydrogen to Accelerate Commercialization of AEM Water Electrolysis for Clean Hydrogen Production TOKYO–(BUSINESS WIRE)– Asahi Kasei, a diversified global company, and U.S.-based Power to Hydrogen (P2H2) have signed a memorandum of understanding (MOU) to evaluate manufacturing scale-up and commercialization of water electrolysis systems utilizing anion exchange membrane (AEM) technology to produce clean hydrogen. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104604751/en/ Power to Hydrogen CEO Dr. Paul Matter (left) and Kenji Takeda, Lead Executive Officer of Asahi Kasei (right) As the hydrogen industry seeks to reduce production costs, secure material supply, and improve compatibility with […]